2-(56-Dimethyl-9-Oxoxanthen-4-Yl)Acetic Acid 98.0%(HPLC)
98.0%(HPLC)
Properties
| Vapour pressure | 1.12E-11mmHg at 25℃ |
| Assay Purity | >98%(HPLC) |
| Refractive index | 1.633 |
| B pt. | 520.9℃ at 760mmHg |
| M pt. | 264℃ |
| Density | 1.321g/cm3 |
Safety Information
| Hazard Statement(s) | H302 |
| Precautionary Statement | P501-P270-P264-P301 + P312 + P330 |
| Symbol |
|
| Signal word | Warning |
| HS Code | 2932999099 |
| Flash point | 197.1℃ |
| Storage Temp. | 0-10℃ |
| Storage Class | 9 |
| Packaging | Glass bottle |
| UN Number | 3077 |
Description
Application
56-dimethylxanthenone-4-acetic acid (DMXAA) has been used to induce type-I IFN signaling in a stimulator of interferon genes (STING) dependent manner.It has also been used to study STING-dependent signaling in the absence of infection.
Purpose
For R&D use onlynot for drug household or other uses.
General Description
Vadimezan is a drug that displayed vascular-disrupting activity and induced haemorrhagic necrosis and tumour regression in pre-clinical animal models.
Documents
| SDS |
| COA |
| Specification |
| Bulk quote order form |